Quality CDMOJune 16, 2023

FDA 483 - Quality CDMO - June 16, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Quality CDMO

Record Details

An FDA inspection of QUALITY CDMO, Inc. in Fort Worth, TX, a drug manufacturer, revealed significant deficiencies in their manufacturing processes. The firm failed to validate drug manufacturing equipment, equipment qualifications, and cleaning procedures for OTC and Rx drug products. Additionally, the quality control unit lacked proper authority for change control, and the firm had not established hold time studies for bulk drug products.

Company: Quality CDMO
Inspection Date: June 16, 2023
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West III
People: Marvin D. Jones (Investigator)
Martrice A. Packer (Program Coordinator)
Regan T. Harp (Investigator)

Open in Dashboard

ID · 5067cfa6-ea85-4517-ae8e-91e1878fd7e5